The antioxidant properties of serum albumin

FEBS Letters

Volumn 582, Issue 13, 2008, Pages 1783-1787

  Roche, Marjolaine ^a   Rondeau, Philippe ^a   Singh, Nihar Ranjan ^a   Tarnus, Evelyne ^a   Bourdon, Emmanuel ^a  

^a UNIVERSITÉ DE LA RÉUNION   (France)

Author keywords

Antioxidant; Oxidation; Oxidative stress; Serum albumin

Indexed keywords

AMINO ACID; FREE RADICAL; SERUM ALBUMIN;

ANTIOXIDANT ACTIVITY; BLOOD VESSEL PERMEABILITY; CARDIOVASCULAR RISK; CATABOLISM; CONCENTRATION (PARAMETERS); FENTON REACTION; HUMAN; LIGAND BINDING; MOLECULAR WEIGHT; OXIDATION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SHORT SURVEY;

FREE RADICAL SCAVENGERS; FREE RADICALS; HUMANS; LIGANDS; OXIDATION-REDUCTION; SERUM ALBUMIN;

MAMMALIA;

EID: 44449128155     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2008.04.057     Document Type: Short Survey

References (61)

1. Sies H. Oxidative stress: from basic research to clinical application. Am. J. Med. 91 (1991) 31S-38S
2. Halliwell B., and Whiteman M. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?. Br. J. Pharmacol. 142 (2004) 231-255
3. Brahimi-Horn M.C., and Pouyssegur J. Oxygen, a source of life and stress. FEBS Lett. 581 (2007) 3582-3591
4. Musante L., Bruschi M., Candiano G., Petretto A., Dimasi N., Del Boccio P., Urbani A., Rialdi G., and Ghiggeri G.M. Characterization of oxidation end product of plasma albumin 'in vivo'. Biochem. Biophys. Res. Commun. 349 (2006) 668-673
5. Cha M.K., and Kim I.H. Glutathione-linked thiol peroxidase activity of human serum albumin: a possible antioxidant role of serum albumin in blood plasma. Biochem. Biophys. Res. Commun. 222 (1996) 619-625
6. Bourdon E., Loreau N., and Blache D. Glucose and free radicals impair the antioxidant properties of serum albumin. FASEB J. 13 (1999) 233-244
7. Bourdon E., Loreau N., Lagrost L., and Blache D. Differential effects of cysteine and methionine residues in the antioxidant activity of human serum albumin. Free Radic. Res. 39 (2005) 15-20
8. Lee H., Cha M.K., and Kim I.H. Activation of thiol-dependent antioxidant activity of human serum albumin by alkaline pH is due to the B-like conformational change. Arch. Biochem. Biophys. 380 (2000) 309-318
9. Rondeau P., Armenta S., Caillens H., Chesne S., and Bourdon E. Assessment of temperature effects on beta-aggregation of native and glycated albumin by FTIR spectroscopy and PAGE: relations between structural changes and antioxidant properties. Arch. Biochem. Biophys. 460 (2007) 141-150
10. Peters T.J. All About Albumin (1996), Academic Press, San Diego
11. Bourdon E., and Blache D. The importance of proteins in defense against oxidation. Antioxid. Redox Signal. 3 (2001) 293-311
12. Cross C.E., van der Vliet A., O'Neill C.A., Louie S., and Halliwell B. Oxidants, antioxidants, and respiratory tract lining fluids. Environ. Health Perspect. 102 Suppl. 10 (1994) 185-191
13. Halliwell B. Albumin - an important extracellular antioxidant?. Biochem. Pharmacol. 37 (1988) 569-571
14. Laussac J.P., and Sarkar B. Characterization of the copper(II)- and nickel(II)-transport site of human serum albumin. Studies of copper(II) and nickel(II) binding to peptide 1-24 of human serum albumin by 13C and 1H NMR spectroscopy. Biochemistry 23 (1984) 2832-2838
15. Chevion M., Jiang Y., Har-El R., Berenshtein E., Uretzky G., and Kitrossky N. Copper and iron are mobilized following myocardial ischemia: possible predictive criteria for tissue injury. Proc. Natl. Acad. Sci. USA 90 (1993) 1102-1106
16. Wei C., Nguyen S.D., Kim M.R., and Sok D.E. Rice albumin N-terminal (Asp-His-His-Gln) prevents against copper ion-catalyzed oxidations. J. Agric. Food Chem. 55 (2007) 2149-2154
17. Lim P.S., Cheng Y.M., and Yang S.M. Impairments of the biological properties of serum albumin in patients on haemodialysis. Nephrology (Carlton) 12 (2007) 18-24
18. Bar-Or D., Rael L.T., Lau E.P., Rao N.K., Thomas G.W., Winkler J.V., Yukl R.L., Kingston R.G., and Curtis C.G. An analog of the human albumin N-terminus (Asp-Ala-His-Lys) prevents formation of copper-induced reactive oxygen species. Biochem. Biophys. Res. Commun. 284 (2001) 856-862
19. Gum E.T., Swanson R.A., Alano C., Liu J., Hong S., Weinstein P.R., and Panter S.S. Human serum albumin and its N-terminal tetrapeptide (DAHK) block oxidant-induced neuronal death. Stroke 35 (2004) 590-595
20. Walter P.B., Fung E.B., Killilea D.W., Jiang Q., Hudes M., Madden J., Porter J., Evans P., Vichinsky E., and Harmatz P. Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease. Br. J. Haematol. 135 (2006) 254-263
21. Rubbo H., Parthasarathy S., Barnes S., Kirk M., Kalyanaraman B., and Freeman B.A. Nitric oxide inhibition of lipoxygenase-dependent liposome and low-density lipoprotein oxidation: termination of radical chain propagation reactions and formation of nitrogen-containing oxidized lipid derivatives. Arch. Biochem. Biophys. 324 (1995) 15-25
22. Quinlan G.J., Martin G.S., and Evans T.W. Albumin: biochemical properties and therapeutic potential. Hepatology 41 (2005) 1211-1219
23. van Reyk D.M., Brown A.J., Hult'en L.M., Dean R.T., and Jessup W. Oxysterols in biological systems: sources, metabolism and pathophysiological relevance. Redox Rep. 11 (2006) 255-262
24. Lin C.Y., and Morel D.W. Esterification of oxysterols in human serum: effects on distribution and cellular uptake. J. Lipid Res. 37 (1996) 168-178
25. Jacobsen C. Lysine residue 240 of human serum albumin is involved in high-affinity binding of bilirubin. Biochem. J. 171 (1978) 453-459
26. Neuzil J., and Stocker R. Bilirubin attenuates radical-mediated damage to serum albumin. FEBS Lett. 331 (1993) 281-284
27. Neuzil J., and Stocker R. Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation. J. Biol. Chem. 269 (1994) 16712-16719
28. Wu T.W., Wu J., Li R.K., Mickle D., and Carey D. Albumin-bound bilirubins protect human ventricular myocytes against oxyradical damage. Biochem. Cell Biol. 69 (1991) 683-688
29. Papatheodorou L., and Weiss N. Vascular oxidant stress and inflammation in hyperhomocysteinemia. Antioxid. Redox Signal. 9 (2007) 1941-1958
30. Oettl K., and Stauber R.E. Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties. Br. J. Pharmacol. 151 (2007) 580-590
31. Gutteridge J.M. Antioxidant properties of the proteins caeruloplasmin, albumin and transferrin. A study of their activity in serum and synovial fluid from patients with rheumatoid arthritis. Biochim. Biophys. Acta 869 (1986) 119-127
32. Carballal S., Alvarez B., Turell L., Botti H., Freeman B.A., and Radi R. Sulfenic acid in human serum albumin. Amino Acids 32 (2007) 543-551
33. Pacher P., Beckman J.S., and Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 87 (2007) 315-424
34. Carballal S., Radi R., Kirk M.C., Barnes S., Freeman B.A., and Alvarez B. Sulfenic acid formation in human serum albumin by hydrogen peroxide and peroxynitrite. Biochemistry 42 (2003) 9906-9914
35. Berlett B.S., and Stadtman E.R. Protein oxidation in aging, disease, and oxidative stress. J. Biol. Chem. 272 (1997) 20313-20316
36. Levine R.L., Mosoni L., Berlett B.S., and Stadtman E.R. Methionine residues as endogenous antioxidants in proteins. Proc. Natl. Acad. Sci. USA 93 (1996) 15036-15040
37. Levine R.L., Berlett B.S., Moskovitz J., Mosoni L., and Stadtman E.R. Methionine residues may protect proteins from critical oxidative damage. Mech. Ageing Dev. 107 (1999) 323-332
38. Weiss S.J. Tissue destruction by neutrophils. New Engl. J. Med. 320 (1989) 365-376
39. Winterbourn C.C., Vissers M.C., and Kettle A.J. Myeloperoxidase. Curr. Opin. Hematol. 7 (2000) 53-58
40. Halliwell B., and Gutteridge J.M. The antioxidants of human extracellular fluids. Arch. Biochem. Biophys. 280 (1990) 1-8
41. Cohen M.P. Intervention strategies to prevent pathogenetic effects of glycated albumin. Arch. Biochem. Biophys. 419 (2003) 25-30
42. Cohen M.P., Shea E., Chen S., and Shearman C.W. Glycated albumin increases oxidative stress, activates NF-kappa B and extracellular signal-regulated kinase (ERK), and stimulates ERK-dependent transforming growth factor-beta 1 production in macrophage RAW cells. J. Lab. Clin. Med. 141 (2003) 242-249
43. Faure P., Troncy L., Lecomte M., Wiernsperger N., Lagarde M., Ruggiero D., and Halimi S. Albumin antioxidant capacity is modified by methylglyoxal. Diabetes Metab. 31 (2005) 169-177
44. Faure P., Wiernsperger N., Polge C., Favier A., and Halimi S. Impairment of the antioxidant properties of serum albumin in diabetic patients: protective effects of metformin. Clin. Sci. (Lond.) (2007)
45. Sakata N., Moh A., and Takebayashi S. Contribution of superoxide to reduced antioxidant activity of glycoxidative serum albumin. Heart Vessels 17 (2002) 22-29
46. Van Campenhout A., Van Campenhout C., Lagrou A.R., Moorkens G., De Block C., and Manuel-y-Keenoy B. Iron-binding antioxidant capacity is impaired in diabetes mellitus. Free Radic. Biol. Med. 40 (2006) 1749-1755
47. Barzegar A., Moosavi-Movahedi A.A., Sattarahmady N., Hosseinpour-Faizi M.A., Aminbakhsh M., Ahmad F., Saboury A.A., Ganjali M.R., and Norouzi P. Spectroscopic studies of the effects of glycation of human serum albumin on L-Trp binding. Protein Pept. Lett. 14 (2007) 13-18
48. Chesne S., Rondeau P., Armenta S., and Bourdon E. Effects of oxidative modifications induced by the glycation of bovine serum albumin on its structure and on cultured adipose cells. Biochimie 88 (2006) 1467-1477
49. Singh N.R., Rondeau P., Hoareau L., and Bourdon E. Identification of preferential protein targets for carbonylation in human mature adipocytes treated with native or glycated albumin. Free Radic. Res. 41 (2007) 1078-1088
50. Goldin A., Beckman J.A., Schmidt A.M., and Creager M.A. Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 114 (2006) 597-605
51. Mera K., Nagai R., Haraguchi N., Fujiwara Y., Araki T., Sakata N., and Otagiri M. Hypochlorous acid generates N epsilon-(carboxymethyl)lysine from Amadori products. Free Radic. Res. 41 (2007) 713-718
52. Xu B., Chibber R., Ruggiero D., Kohner E., Ritter J., and Ferro A. Impairment of vascular endothelial nitric oxide synthase activity by advanced glycation end products. FASEB J. 17 (2003) 1289-1291
53. Nagai R., Mera K., Nakajou K., Fujiwara Y., Iwao Y., Imai H., Murata T., and Otagiri M. The ligand activity of AGE-proteins to scavenger receptors is dependent on their rate of modification by AGEs. Biochim. Biophys. Acta 1772 (2007) 1192-1198
54. Marsche, G., Semlitsch, M., Hammer, A., Frank, S., Weigle, B., Demling, N., Schmidt, K., Windischhofer, W., Waeg, G., Sattler, W. and Malle, E. (2007) Hypochlorite-modified albumin colocalizes with RAGE in the artery wall and promotes MCP-1 expression via the RAGE-Erk1/2 MAP-kinase pathway. FASEB J. fj.06-7439com.
55. Stolzing A., Widmer R., Jung T., Voss P., and Grune T. Degradation of glycated bovine serum albumin in microglial cells. Free Radic. Biol. Med. 40 (2006) 1017-1027
56. de Arriba S.G., Krugel U., Regenthal R., Vissiennon Z., Verdaguer E., Lewerenz A., Garcia-Jorda E., Pallas M., Camins A., Munch G., Nieber K., and Allgaier C. Carbonyl stress and NMDA receptor activation contribute to methylglyoxal neurotoxicity. Free Radic. Biol. Med. 40 (2006) 779-790
57. Vitek M.P., Bhattacharya K., Glendening J.M., Stopa E., Vlassara H., Bucala R., Manogue K., and Cerami A. Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc. Natl. Acad. Sci. USA 91 (1994) 4766-4770
58. Quinlan G.J., Evans T.W., and Gutteridge J.M. Linoleic acid and protein thiol changes suggestive of oxidative damage in the plasma of patients with adult respiratory distress syndrome. Free Radic. Res. 20 (1994) 299-306
59. Quinlan G.J., Mumby S., Martin G.S., Bernard G.R., Gutteridge J.M., and Evans T.W. Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury. Crit. Care Med. 32 (2004) 755-759
60. Faure P., Tamisier R., Baguet J.P., Favier A., Halimi S., Lévy P., and Pépin J.L. Impairment of serum albumin antioxidant properties in obstructive sleep apnoea syndrome. Eur. Respir. J. 31 (2008) 1046-1053
61. Ghuman J., Zunszain P.A., Petitpas I., Bhattacharya A.A., Otagiri M., and Curry S. Structural basis of the drug-binding specificity of human serum albumin. J. Mol. Biol. 353 (2005) 38-52